Syncom Formulations (India) Limited Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Syncom Formulations (India) Limited cash flow conversion efficiency. Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Syncom Formulations (India) Limited (2006–2025)

Cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SYNCOMF stock price for real-time trading data and today's change.

Syncom Formulations (India) Limited Cash Flow Conversion Ratio Explained

Syncom Formulations (India) Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency. Also see market cap of Syncom Formulations (India) Limited for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Kross Ltd
NSE:KROSS
0.010x
Uxin Ltd
NASDAQ:UXIN
-2.472x
Site Centers Corp
NYSE:SITC
-0.013x
Arise Windpower AB
ST:ARISE
0.147x
Henan BCCY Environmental Energy Co. Ltd
SHE:300614
N/A
D2L Inc
TO:DTOL
0.402x
Vef AB
ST:VEFAB
-0.001x
Embention Sistemas Inteligentes S.A.
PA:MLUAV
N/A

Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. Review Syncom Formulations (India) Limited (SYNCOMF) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs3.42 Billion
≈ $37.00 Million
Rs234.36 Million
≈ $2.53 Million
0.068x +430.29%
2024-03-31 Rs2.87 Billion
≈ $31.07 Million
Rs-59.58 Million
≈ $-644.37K
-0.021x -150.42%
2023-03-31 Rs2.56 Billion
≈ $27.69 Million
Rs105.29 Million
≈ $1.14 Million
0.041x -44.03%
2022-03-31 Rs2.22 Billion
≈ $24.03 Million
Rs163.29 Million
≈ $1.77 Million
0.073x +791.44%
2021-03-31 Rs1.88 Billion
≈ $20.29 Million
Rs-19.93 Million
≈ $-215.59K
-0.011x -206.10%
2020-03-31 Rs1.46 Billion
≈ $15.75 Million
Rs-5.06 Million
≈ $-54.69K
-0.003x -110.64%
2019-03-31 Rs1.33 Billion
≈ $14.34 Million
Rs43.29 Million
≈ $468.17K
0.033x +348.68%
2018-03-31 Rs1.22 Billion
≈ $13.19 Million
Rs-16.01 Million
≈ $-173.10K
-0.013x -111.13%
2017-03-31 Rs1.17 Billion
≈ $12.69 Million
Rs138.41 Million
≈ $1.50 Million
0.118x -46.97%
2016-03-31 Rs1.09 Billion
≈ $11.76 Million
Rs241.74 Million
≈ $2.61 Million
0.222x +11832.06%
2015-03-31 Rs1.00 Billion
≈ $10.84 Million
Rs1.87 Million
≈ $20.20K
0.002x -97.36%
2014-03-31 Rs951.99 Million
≈ $10.30 Million
Rs67.30 Million
≈ $727.87K
0.071x +7.30%
2013-03-31 Rs877.09 Million
≈ $9.49 Million
Rs57.79 Million
≈ $624.96K
0.066x -14.20%
2012-03-31 Rs836.08 Million
≈ $9.04 Million
Rs64.20 Million
≈ $694.33K
0.077x +281.55%
2011-03-31 Rs816.58 Million
≈ $8.83 Million
Rs-34.54 Million
≈ $-373.52K
-0.042x -381.24%
2010-03-31 Rs550.47 Million
≈ $5.95 Million
Rs-4.84 Million
≈ $-52.32K
-0.009x +51.59%
2009-03-31 Rs411.32 Million
≈ $4.45 Million
Rs-7.47 Million
≈ $-80.76K
-0.018x -112.90%
2008-03-31 Rs390.34 Million
≈ $4.22 Million
Rs54.94 Million
≈ $594.11K
0.141x -0.43%
2007-03-31 Rs342.37 Million
≈ $3.70 Million
Rs48.40 Million
≈ $523.37K
0.141x +69.71%
2006-03-31 Rs292.59 Million
≈ $3.16 Million
Rs24.37 Million
≈ $263.55K
0.083x --

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic
Market Cap
$195.59 Million
Rs18.09 Billion INR
Market Cap Rank
#16443 Global
#842 in India
Share Price
Rs19.24
Change (1 day)
-5.73%
52-Week Range
Rs10.30 - Rs26.18
All Time High
Rs26.77
About

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more